Prevention of spontaneous mammary adenocarcinoma in HER‐2/neu transgenic mice by foreign DNA
- 1 November 2002
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 16 (13) , 1749-1754
- https://doi.org/10.1096/fj.02-0383com
Abstract
Unmethylated CpG-oligodeoxynucleotides (CpG-ODNs) are recognized as a 'danger signal' and are potent immunostimulators. To test whether tumors might be prevented by maintaining the innate immune system on continuous alert, proto-neu transgenic female mice, which develop spontaneous mammary tumors, were systemically treated with CpG-ODNs at 10-day intervals. Tumor incidence and number of tumors/mouse were significantly lower in treated mice compared with the control group. Moreover, CpG-ODN systemic treatment significantly reduced lung metastases induced by intravenous inoculation of N202.1A cells derived from a spontaneous mammary carcinoma. Growth of established tumors was modestly inhibited after CpG-ODN systemic treatment but strongly on peritumoral application. Our data indicate that systemic repeated injection of CpG-ODN to maintain the innate immune system on continuous alert prevents the onset of genetically determined tumors and confers tumor protection when the tumor load is low.Keywords
Funding Information
- Associazione Italiana per la Ricerca sul Cancro
- Foundation for Ichthyosis and Related Skin Types
- Fondazione Italiana per la Ricerca sul Cancro
This publication has 19 references indexed in Scilit:
- Absence of the CD1 Molecule Up-Regulates Antitumor Activity Induced by CpG Oligodeoxynucleotides in MiceThe Journal of Immunology, 2002
- NK- and CD8+ T Cell-Mediated Eradication of Established Tumors by Peritumoral Injection of CpG-Containing OligodeoxynucleotidesThe Journal of Immunology, 2001
- Prevention of spontaneous neu-expressing mammary tumor development in mice transgenic for rat proto-neu by DNA vaccinationGene Therapy, 2001
- Immune Recognition of Foreign DNAImmunity, 1999
- Anti-tumor immunity induced by murine melanoma cells transduced with the Mycobacterium tuberculosis gene encoding the 38-kDa antigenGene Therapy, 1998
- Immunostimulatory DNA: Sequence‐dependent production of potentially harmful or useful cytokinesEuropean Journal of Immunology, 1997
- Antisense c-mycInhibition of Lymphoma GrowthAntisense and Nucleic Acid Drug Development, 1997
- CpG motifs in bacterial DNA trigger direct B-cell activationNature, 1995
- Tolerance, Danger, and the Extended FamilyAnnual Review of Immunology, 1994
- Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease.Proceedings of the National Academy of Sciences, 1992